- Report
- April 2026
- 220 Pages
Mexico
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 221 Pages
Netherlands
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 222 Pages
China
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 223 Pages
Saudi Arabia
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 224 Pages
South Africa
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 225 Pages
South Korea
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 226 Pages
Spain
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 227 Pages
Thailand
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 228 Pages
Turkey
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2026
- 229 Pages
United Kingdom
From €4295EUR$4,850USD£3,680GBP
- Report
- April 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- March 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- March 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- September 2024
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,234USD£3,104GBP
- Report
- August 2025
- 90 Pages
Global
From €3500EUR$4,234USD£3,104GBP
- Report
- August 2025
- 100 Pages
Global
From €3500EUR$4,234USD£3,104GBP
- Report
- August 2025
- 98 Pages
Global
From €3500EUR$4,234USD£3,104GBP
- Report
- July 2025
- 85 Pages
Global
From €3500EUR$4,234USD£3,104GBP
- Report
- July 2025
- 86 Pages
Global
From €3500EUR$4,234USD£3,104GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more